https://doi.org/
Poster
NOT PEER REVIEWED
Download
metrics
VIEWS
1097
 
downloads
128
CITE
How to cite this poster:
Schnadig ID, Bhor M, Vogelzang NJ et al. Sequencing of cabazitaxel and abiraterone acetate following docetaxel in metastatic castration-resistant prostate cancer (mCRPC). F1000Posters 2013, 4:247 (poster)

Sequencing of cabazitaxel and abiraterone acetate following docetaxel in metastatic castration-resistant prostate cancer (mCRPC)

Ian D Schnadig1, Menaka Bhor, Nicholas J Vogelzang, Daniel Hennessy, Leonardo Nicacio, William R Berry, Thomas E Hutson, Mark T Fleming, C Lance Cowey, Shanmugapriya Saravanan, Rahul Dhanda, Guru Sonpavde
Published 13 May 2013
Author Affiliations
  • Metrics
  • 1097 Views
  • 128 Downloads
Browse by related subjects
Published 13 May 2013

Sequencing of cabazitaxel and abiraterone acetate following docetaxel in metastatic castration-resistant prostate cancer (mCRPC)

[version 1; not peer reviewed]

Ian D Schnadig1, Menaka Bhor, Nicholas J Vogelzang, Daniel Hennessy, Leonardo Nicacio, William R Berry, Thomas E Hutson, Mark T Fleming, C Lance Cowey, Shanmugapriya Saravanan, Rahul Dhanda, Guru Sonpavde
Author Affiliations
1 Sanofi, USA
Presented at
Genitourinary Cancers Symposium 2013
Abstract
Competing Interests

McKesson Specialty Health received support for this publication from Sanofi US.

Comments
0 Comments
 
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.